Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in korea: A nationwide randomized trial

Joon Sung Kim, Byung Wook Kim, Su Jin Hong, Jin Il Kim, Ki Nam Shim, Jie Hyun Kim, Gwang Ho Baik, Sang Wook Kim, Hyun Joo Song, Ji Hyun Kim

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background/Aims: Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study was to compare the efficacy of ST with TT. Methods: This was a multicenter, randomized open-label trial performed at nine centers in Korea. Patients with H. pylori infection were randomly assigned to receive either 7 day TT or 10 day ST. Eradication rates, drug compliance, and adverse events were compared among the two regimens. Results: A total of 601 patients were enrolled between March 2011 and September 2014. The intention-to-treat eradication rates were 70.8% for TT and 82.4% for ST (p=0.001). The corresponding per protocol eradication rates were 76.9% and 88.8% for TT and ST, respectively (p=0.000). There were no statistically significant differences between the two regimens with respect to drug compliance and adverse events. Conclusions: ST achieved better eradication rates than TT as a first-line therapy for H. pylori eradication in Korea.

Original languageEnglish
Pages (from-to)556-561
Number of pages6
JournalGut and liver
Volume10
Issue number4
DOIs
Publication statusPublished - 2016 Jul

Fingerprint

Korea
Helicobacter pylori
Therapeutics
Helicobacter Infections
Drug-Related Side Effects and Adverse Reactions
Compliance
Microbial Drug Resistance

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Kim, Joon Sung ; Kim, Byung Wook ; Hong, Su Jin ; Kim, Jin Il ; Shim, Ki Nam ; Kim, Jie Hyun ; Baik, Gwang Ho ; Kim, Sang Wook ; Song, Hyun Joo ; Kim, Ji Hyun. / Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in korea : A nationwide randomized trial. In: Gut and liver. 2016 ; Vol. 10, No. 4. pp. 556-561.
@article{e6eeaf917697470595c49433316c75b4,
title = "Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in korea: A nationwide randomized trial",
abstract = "Background/Aims: Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study was to compare the efficacy of ST with TT. Methods: This was a multicenter, randomized open-label trial performed at nine centers in Korea. Patients with H. pylori infection were randomly assigned to receive either 7 day TT or 10 day ST. Eradication rates, drug compliance, and adverse events were compared among the two regimens. Results: A total of 601 patients were enrolled between March 2011 and September 2014. The intention-to-treat eradication rates were 70.8{\%} for TT and 82.4{\%} for ST (p=0.001). The corresponding per protocol eradication rates were 76.9{\%} and 88.8{\%} for TT and ST, respectively (p=0.000). There were no statistically significant differences between the two regimens with respect to drug compliance and adverse events. Conclusions: ST achieved better eradication rates than TT as a first-line therapy for H. pylori eradication in Korea.",
author = "Kim, {Joon Sung} and Kim, {Byung Wook} and Hong, {Su Jin} and Kim, {Jin Il} and Shim, {Ki Nam} and Kim, {Jie Hyun} and Baik, {Gwang Ho} and Kim, {Sang Wook} and Song, {Hyun Joo} and Kim, {Ji Hyun}",
year = "2016",
month = "7",
doi = "10.5009/gnl15470",
language = "English",
volume = "10",
pages = "556--561",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "4",

}

Kim, JS, Kim, BW, Hong, SJ, Kim, JI, Shim, KN, Kim, JH, Baik, GH, Kim, SW, Song, HJ & Kim, JH 2016, 'Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in korea: A nationwide randomized trial', Gut and liver, vol. 10, no. 4, pp. 556-561. https://doi.org/10.5009/gnl15470

Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in korea : A nationwide randomized trial. / Kim, Joon Sung; Kim, Byung Wook; Hong, Su Jin; Kim, Jin Il; Shim, Ki Nam; Kim, Jie Hyun; Baik, Gwang Ho; Kim, Sang Wook; Song, Hyun Joo; Kim, Ji Hyun.

In: Gut and liver, Vol. 10, No. 4, 07.2016, p. 556-561.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in korea

T2 - A nationwide randomized trial

AU - Kim, Joon Sung

AU - Kim, Byung Wook

AU - Hong, Su Jin

AU - Kim, Jin Il

AU - Shim, Ki Nam

AU - Kim, Jie Hyun

AU - Baik, Gwang Ho

AU - Kim, Sang Wook

AU - Song, Hyun Joo

AU - Kim, Ji Hyun

PY - 2016/7

Y1 - 2016/7

N2 - Background/Aims: Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study was to compare the efficacy of ST with TT. Methods: This was a multicenter, randomized open-label trial performed at nine centers in Korea. Patients with H. pylori infection were randomly assigned to receive either 7 day TT or 10 day ST. Eradication rates, drug compliance, and adverse events were compared among the two regimens. Results: A total of 601 patients were enrolled between March 2011 and September 2014. The intention-to-treat eradication rates were 70.8% for TT and 82.4% for ST (p=0.001). The corresponding per protocol eradication rates were 76.9% and 88.8% for TT and ST, respectively (p=0.000). There were no statistically significant differences between the two regimens with respect to drug compliance and adverse events. Conclusions: ST achieved better eradication rates than TT as a first-line therapy for H. pylori eradication in Korea.

AB - Background/Aims: Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study was to compare the efficacy of ST with TT. Methods: This was a multicenter, randomized open-label trial performed at nine centers in Korea. Patients with H. pylori infection were randomly assigned to receive either 7 day TT or 10 day ST. Eradication rates, drug compliance, and adverse events were compared among the two regimens. Results: A total of 601 patients were enrolled between March 2011 and September 2014. The intention-to-treat eradication rates were 70.8% for TT and 82.4% for ST (p=0.001). The corresponding per protocol eradication rates were 76.9% and 88.8% for TT and ST, respectively (p=0.000). There were no statistically significant differences between the two regimens with respect to drug compliance and adverse events. Conclusions: ST achieved better eradication rates than TT as a first-line therapy for H. pylori eradication in Korea.

UR - http://www.scopus.com/inward/record.url?scp=84978512282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978512282&partnerID=8YFLogxK

U2 - 10.5009/gnl15470

DO - 10.5009/gnl15470

M3 - Article

C2 - 27114421

AN - SCOPUS:84978512282

VL - 10

SP - 556

EP - 561

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 4

ER -